Sells medical imaging and patient-monitoring equipment, pharmaceutical diagnostic agents, and software to hospitals, health systems, and researchers.
10-K for FY2025, filed Feb 4, 2026We generate revenue from the sale of medical devices, consumable products, service capabilities, and AI-enabled cloud and software…View ↗
Our Imaging segment includes five product lines and associated service capabilities: Molecular Imaging (“MI”), Computed Tomography (“CT”)…View ↗
Our PCS segment serves care teams and healthcare systems across multiple patient care needs including Monitoring Solutions and Life Support…View ↗
Our PDx segment supplies contrast and radiopharmaceutical imaging agents to the global radiology and nuclear medicine industries. These…View ↗
Customers generally pay for products around delivery and acceptance; the company also earns from services, including maintenance, repairs, warranties, training, parts and upgrades. Service-type warranties and extended warranties are paid for over time, while payment terms are generally within 12 months.
10-K for FY2025, filed Feb 4, 2026Our revenues primarily consist of sales of products and services to customers. Products include equipment, imaging agents, software-related…View ↗
The Company recognizes a contract with a customer when there is a legally enforceable agreement between the Company and its customer, the…View ↗
For standard, assurance-type warranties that are provided with products, we estimate the cost that may be incurred during the warranty…View ↗
We primarily recognize revenue from sales of products at the point in time that the customer obtains control, which is generally no earlier…View ↗
10-K for FY2025, filed Feb 4, 2026
FY2025 revenue by product or service ↗$20.6B
10-K for FY2025, filed Feb 4, 2026
$20.6B ↗| Segment | Share | Revenue | How money arrives |
|---|---|---|---|
|
Product
Sold outright
10-K for FY2025, filed Feb 4, 2026 |
66%
FY2022: 66%
|
Product, FY2025
$13.7B Sources
|
Sold outright |
|
Service
Recurring
10-K for FY2025, filed Feb 4, 2026 |
34%
FY2022: 34%
|
Service, FY2025
$7B Sources
|
Recurring |
Hospitals, health systems and researchers—including public, private, academic and government institutions—buy through direct sales teams and third-party partners such as distributors and sales agents.
10-K for FY2025, filed Feb 4, 2026
Yes. It kept 10 cents of every revenue dollar as net income in FY2025.
10-K for FY2025, filed Feb 4, 2026
10-Q for Q2 FY2026, filed Jul 29, 2026
Open tableView ↗
8-K, filed Aug 18, 2026
CHICAGO — August 18, 2026 — GE HealthCare (Nasdaq: GEHC), a leading global precision care innovator, today announced the appointment of…View ↗
8-K, filed Jul 29, 2026
GE HealthCare Technologies Inc. ("GE HealthCare," the “Company,” “our,” “us,” or “we”) is filing this Current Report on Form 8-K to provide…View ↗
8-K, filed Jul 23, 2026
On July 21, 2026, James K. (Jay) Saccaro notified GE HealthCare that he will resign as Chief Financial Officer for a role outside of the…View ↗
Growing. Revenue grew 17% in 4 years, from $17.6B in FY2021 to $20.6B in FY2025, about 4% a year.
Ultrasound organization
The older report described Ultrasound as a standalone business segment. The latest report places Specialized Ultrasound and Procedural Guidance within Advanced Visualization Solutions, alongside Imaging as separate reportable segments.
10-K for FY2022, filed Feb 15, 2023 10-K for FY2025, filed Feb 4, 2026
Competes with Siemens Healthineers, Philips Healthcare, United Imaging, Mindray, Canon, Bayer, Bracco, Guerbet, and Curium
10-K for FY2025, filed Feb 4, 2026The global medical technology industry is highly competitive and includes global and regional participants of all sizes that can vary by…View ↗
Loading...